KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PTPI
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Petros Pharmaceuticals Inc stock price down 0% on Friday
(Updated on Apr 26, 2024)

Sell candidate since Apr 02, 2024 Loss -40.20% PDF

No changes to the price of Petros Pharmaceuticals Inc stock on the last trading day (Friday, 26th Apr 2024). During the last trading day the stock fluctuated 3.86% from a day low at $0.636 to a day high of $0.660. The price has fallen in 6 of the last 10 days and is down by -23.26% for this period.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.611 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -36.04% during the next 3 months and, with a 90% probability hold a price between $0.391 and $0.83 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PTPI Signals & Forecast

There are mixed signals in the stock today. The Petros Pharmaceuticals Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.659 and $1.11. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Wednesday, April 24, 2024, and so far it has risen 0.87%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Petros Pharmaceuticals Inc stock

Petros Pharmaceuticals Inc finds support from accumulated volume at $0.634 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0245 between high and low, or 3.86%. For the last week the stock has had daily average volatility of 8.46%.

Petros Pharmaceuticals Inc is oversold on RSI14 (16). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PTPI) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Petros Pharmaceuticals Inc to open at $0.645, and during the day (based on 14 day Average True Range), to move between $0.542 and $0.738, which gives a possible trading interval of +/-$0.0976 (+/-15.26%) up or down from last closing price. If Petros Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 30.52% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.634 (0.86%) than the resistance at $0.680 (6.28%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Petros Pharmaceuticals Inc stock A Buy?

Petros Pharmaceuticals Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -4.163 Sell Candidate Unchanged

Predicted Opening Price for Petros Pharmaceuticals Inc of Monday, April 29, 2024

Fair opening price April 29, 2024 Current price
$0.645 ( 0.82%) $0.640

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PTPI

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.670 4.65 %
R2 0.660 3.18 %
R1 0.654 2.28 %
Current price: 0.640
Support S1 0.636 -0.645 %
S2 0.630 -1.55 %
S3 0.621 -3.01 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.783 22.38 %
R2 0.705 10.17 %
R1 0.680 6.28 %
Current price 0.640
Support S1 0.634 -0.86%
S2 0 .
S3 0 .

FAQ

What is the symbol for Petros Pharmaceuticals Inc Stock and on which exchange is it traded?
The symbol for Petros Pharmaceuticals Inc is PTPI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Petros Pharmaceuticals Inc Stock?
Petros Pharmaceuticals Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Petros Pharmaceuticals Inc Stock?
Petros Pharmaceuticals Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Petros Pharmaceuticals Inc Stock.

What's the current price of Petros Pharmaceuticals Inc Stock?
As of the end of day on the Apr 26, 2024, the price of an Petros Pharmaceuticals Inc (PTPI) share was $0.640.

What is the 52-week high and low for Petros Pharmaceuticals Inc Stock?
The 52-week high for Petros Pharmaceuticals Inc Stock is $5.24 and the 52-week low is $0.602.

What is the market capitalization of Petros Pharmaceuticals Inc Stock?
As of the Apr 26, 2024, the market capitalization of Petros Pharmaceuticals Inc is 4.4M.
Click to get the best stock tips daily for free!

About Petros Pharmaceuticals Inc

Petros Pharmaceuticals Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for the treatment of acute Peyronie's disease. The company markets its line of ED products in the form of vac... PTPI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT